EU regulators back BMS’ Opdivo in new skin cancer use
Trial tested epacadostat pill in combination with Merck & Co’s Keytruda
Opdivo performed better than BMS’ Yervoy in clinical trial.
Technology could inspire a smartphone-based skin cancer diagnostic app.
Swiss pharma looking to combine immunotherapy with already marketed drugs.
A round-up of this week’s top digital healthcare news. Marco Ricci reports.